The Association of the British Pharmaceutical Industry (ABPI) has appointed Susan Rienow, country president of Pfizer, as its vice president.
“As vice president, she will support the president, Pinder Sahota, general manager and corporate vice president of Novo Nordisk UK, in delivering his priorities. These are improving access to medicines, delivering economic growth and helping to find solutions to big societal challenges such as climate change, AMR, and inequalities,” said ABPI in a statement.
At Pfizer, Susan leads the organisation to bring the power of innovation, data and technology together to transform healthcare and improve outcomes for patients. She previously led Pfizer UK’s vaccines business unit during the Covid-19 pandemic.
Commenting on her appointment, Susan said: “The pharmaceutical industry can play a crucial role in generating the economic growth the UK desperately needs at this point, as well as helping the NHS to recover from the pandemic.
“I look forward to working with the president to make sure that lessons from the pandemic are learned and innovative medicines and vaccines reach the people who need them.”